Premium
Prioritising research into age‐related macular degeneration
Author(s) -
Greener Mark
Publication year - 2019
Publication title -
prescriber
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.106
H-Index - 3
eISSN - 1931-2253
pISSN - 0959-6682
DOI - 10.1002/psb.1759
Subject(s) - life expectancy , macular degeneration , medicine , meaning (existential) , degeneration (medical) , expectancy theory , gerontology , set (abstract data type) , optometry , ophthalmology , environmental health , psychotherapist , population , social psychology , psychology , computer science , programming language
As life expectancy increases, the number of people living with age‐related macular degeneration (AMD) is set to rise dramatically, meaning it could become the next public health crisis. Existing treatments are of limited benefit, but researchers are exploring several avenues that could lead to new therapies.